Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028

Single-use Bioprocessing Market - Global Outlook & Forecast 2023-2028


The global single-use bioprocessing market is expected to grow at a CAGR of 19.74% from 2022 to 2028.

MARKET TRENDS & DRIVERS

New Product Launches

Technological advances have been key in introducing new single-use bioprocess consumables worldwide. Players in the single-use bioprocessing market have launched new products that make single-use bioprocessing safer, easier, and more efficient than ever before. Such factors have allowed companies to gain market share by meeting market demands. Market participants apply for patents on single-use disposable bioprocessing products that protect novel designs. The increasing availability of single-use technology for production applications and the launch of new products creates an environment where companies can quickly and easily adopt the technology and begin reaping the benefits. Companies can now reduce costs and improve efficiency in their production processes by replacing traditional, labor-intensive methods with single-use technology.

Increasing Strategic Acquisitions and Collaborations

The strategic acquisition of single-use technology can enhance adoption across biopharmaceuticals. Single-use technology is a cost-effective and efficient way to streamline operations, reduce waste, and improve quality control. By strategically acquiring high-quality single-use technology, organizations can increase their competitive advantage while reducing costs and increasing efficiency. The strategic acquisition of single-use technology can increase the visibility and control of processes, resulting in increased transparency and compliance with industry regulations. The strategic acquisition of single-use technology can be a powerful tool for organizations looking to reduce costs, increase efficiency, and improve their competitive advantage. In addition, the industry players are adopting partnership strategies to facilitate access to local single-use bioprocessing markets.

Growing Biomanufacturing Capacity and Uptake of Biopharmaceuticals & Biosimilars

The growing biomanufacturing capacity and uptake of biopharmaceuticals and biosimilars drive the single-use bioprocessing market. Single-use bioprocessing provides a valuable platform for producing biopharmaceuticals, biotherapeutics, vaccines, monoclonal antibodies, and biosimilars. With advances in biomanufacturing, single-use bioprocessing offers greater flexibility, shorter process times, improved scalability, lower capital costs, and reduced product contamination risks. Additionally, single-use bioprocessing eliminates the need for extensive cleaning and sterilization of equipment, thus reducing operational costs.

SEGMENTATION INSIGHTS

INSIGHTS BY PRODUCT TYPE

Single-use bioprocessing equipment is a technology that has revolutionized the biopharmaceutical industry. This technology has increased efficiency, flexibility, safety, and cost savings during bioprocessing. Single-use bioprocessing equipment is a system of technologies designed to replace reusable stainless steel and other materials traditionally used in bioprocessing. This equipment uses single-use components, including bags, bioreactors, tubing, syringes, connectors, and filters, disposed of after use. In 2022, the single-use bioprocessing equipment product type held a larger share of the global single-use bioprocessing market.

Segmentation by Product Type
  • Single-use Bioprocessing Equipment
  • Simple & Peripheral Devices
INSIGHTS BY APPLICATION

The global single-use bioprocessing market by application is segmented as monoclonal antibodies (mABs), vaccines, cell therapies, and others. Monoclonal antibodies (mABs) hold the largest industry share by application segment. Single-use bioprocessing is an emerging technology in the biopharmaceutical industry that has revolutionized how monoclonal antibodies (mAbs) are produced. Single-use bioprocessing involves using disposable bioreactors and other components to produce proteins, such as mAbs. Unlike traditional stainless-steel bioreactors, single-use bioreactors can be quickly set up, require minimal cleaning, and reduce the risk of cross-contamination. Due to their complexity and high cost, these advantages make single-use bioprocessing particularly attractive for mAb production.

Segmentation by Application
  • Monoclonal Antibodies (mABs)
  • Vaccines
  • Cell Therapies
  • Others
INSIGHTS BY END-USER

The biopharmaceutical manufacturers segment accounted for over 39% of the global single-use bioprocessing market. This segment dominates the overall market and will likely retain its dominance in the coming years due to its widespread adoption in research and commercial manufacturing applications. Several biopharmaceutical manufacturers have already explored SUB solutions usage in commercial manufacturing. However, their potential benefits are significant, particularly in small-volume manufacturing in modular facilities. Most biopharmaceutical manufacturers, especially large and medium-sized companies, spend over $50 million on equipment annually. It has been witnessed that a high percentage of capital is being spent on single-use bioprocessing by biopharmaceutical manufacturers.

Segmentation by End-users
  • Biopharmaceutical Manufacturers
  • Contract Manufacturing Organizations (CMOs)
  • R&D Companies & Research Institutes
INSIGHTS BY METHOD

The global single-use bioprocessing market by the method is categorized as filtration, storage & transport, cell culture, mixing, and purification. Filtration holds the largest share of the market. Single-use bioprocessing is a method of filtration that has grown increasingly popular in the biotechnology industry. It involves using disposable, self-contained systems to prepare, filter, and process bioproducts. This form of filtration has many advantages, especially for pharmaceutical and biological product manufacturing. Single-use bioprocessing has revolutionized the biotechnology industry. This reduces the need for traditional equipment and infrastructure, resulting in cost savings and improved production efficiency.

Segmentation by Method
  • Filtration
  • Storage & Transport
  • Cell Culture
  • Mixing
  • Purification
INSIGHTS BY WORKFLOW

The upstream workflow segment dominated the global single-use bioprocessing market. Upstream single-use bioprocessing workflow is focused on upstream unit operations such as cell culture, protein expression, and harvest. Over the last decade, advances in this workflow have enabled biopharmaceutical companies to streamline the process, increase product yields, and reduce costs. The upstream single-use bioprocessing workflow advancements have provided biopharmaceutical companies with a more efficient and cost-effective workflow.

Segmentation by Workflow
  • Upstream
  • Downstream
GEOGRAPHICAL ANALYSIS

The single-use bioprocessing market in North America is growing significantly and is expected to grow at a similar pace during the forecast period. Increasing demand for biologics from patients, especially the elderly, high investments in R&D activities by biopharmaceutical companies, and patent expiries of biologics are the key drivers for the single-use bioprocessing market in North America. North America, especially the U.S., is known for its in-house biopharmaceutical manufacturing facilities, which have bolstered the adoption of disposables (simple and peripheral devices) and highly advanced single-use systems such as mixing systems, bioreactors, and cell culture systems over the past few years.

Segmentation by Geography
  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Switzerland
  • The U.K.
  • Italy
  • Spain
  • APAC
  • China
  • Japan
  • Australia
  • South Korea
  • India
  • Latin America
  • Brazil
  • Mexico
  • Colombia
  • Argentina
  • Middle East & Africa
  • Turkey
  • Saudi Arabia
  • UAE
  • South Africa
VENDOR LANDSCAPE

The global single-use bioprocessing market is highly dynamic and offers significant growth opportunities for vendors. Although the industry is characterized by the presence of several global as well as local players, a few major global players hold significant shares, offering a broad range of SUTs. As the market offers tremendous growth opportunities, new players are expected to enter, intensifying the competition. Rising competition among SUT manufacturers is expected to drive significant product development, such as providing single-use bioreactors with large manufacturing volumes and capacities.

Key Company Profiles
  • Thermo Fisher Scientific
  • Sartorius Stedim Biotech
  • Danaher
  • Merck KGaA
  • Avantor
Other Prominent Vendors
  • 3i Group
  • 3M
  • ABEC
  • Adolf Kühner
  • AdvantaPure
  • Barry-Wehmiller Companies
  • Broadley-James
  • Celltainer Biotech
  • CerCell A/S
  • CESCO Bioengineering
  • Charter Medical
  • Colder Products Company
  • Corning
  • Distek
  • DrM, Dr. Mueller
  • Emerson Electric
  • Entegris
  • Eppendorf
  • Foxx Life Sciences
  • Getinge
  • HIGH PURITY NEW ENGLAND
  • Holland Applied Technologies
  • Lonza
  • MEISSNER FILTRATION PRODUCTS
  • New Horizon Biotech
  • OmniBRx Biotechnologies
  • PARKER HANNIFIN
  • PendoTECH
  • PBS Biotech
  • Repligen
  • Saint-Gobain
  • Sentinel Process Systems
  • Solaris Biotechnology
  • SYSBIOTECH GmbH
  • Watson-Marlow Fluid Technology Solutions
  • Weigao Group
  • W.L. Gore & Associates
KEY QUESTIONS ANSWERED:

1. How big is the global single-use bioprocessing market?

2. What is the growth rate of the single-use bioprocessing market?

3. What are the rising trends in the single-use bioprocessing market?

4. Which region holds the most significant global single-use bioprocessing market share?

5. Who are the key players in the global single-use bioprocessing market?


1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY PRODUCT
4.3.2 MARKET SEGMENTATION BY APPLICATION
4.3.3 MARKET SEGMENTATION BY END-USERS
4.3.4 MARKET SEGMENTATION BY METHOD
4.3.5 MARKET SEGMENTATION BY WORKFLOW
4.3.6 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 PREMIUM INSIGHTS
6.1 MARKET OVERVIEW
6.1.1 GEOGRAPHY INSIGHTS
6.1.2 PRODUCT TYPE INSIGHTS
6.1.3 APPLICATION INSIGHTS
6.1.4 END-USER INSIGHTS
6.1.5 METHOD INSIGHTS
6.1.6 WORKFLOW INSIGHTS
7 MARKET AT A GLANCE
8 INTRODUCTION
8.1 OVERVIEW
9 MARKET OPPORTUNITIES & TRENDS
9.1 SINGLE-USE TECHNOLOGY IN CELL AND GENE THERAPY
9.2 INCREASING DEMAND FOR CONTINUOUS BIOPROCESSING
9.3 TECHNOLOGICAL ADVANCES IN SINGLE-USE BIOPROCESSING (SUB)
9.4 NEW PRODUCT LAUNCHES
9.5 INCREASING STRATEGIC ACQUISITIONS AND COLLABORATIONS
10 MARKET GROWTH ENABLERS
10.1 GROWING BIOMANUFACTURING CAPACITY AND UPTAKE OF BIOPHARMACEUTICALS & BIOSIMILARS
10.2 LOWER CAPITAL INVESTMENT IN SUTS OVER MULTI-USE PLATFORMS AND LESS FLOOR SPACE REQUIREMENTS
10.3 INCREASED ACCEPTANCE OF SUS TO ENHANCE BIOMANUFACTURING PRODUCTIVITY AND EFFICIENCY
10.4 REDUCED WATER CONSUMPTION AND LESSER ENVIRONMENTAL IMPACT OF SINGLE-USE TECHNOLOGIES
11 MARKET RESTRAINTS
11.1 THE CHANGING SCALE OF SINGLE-USE OPERATIONS
11.2 LOW STRENGTH OF SUPPLY CHAIN AND LACK OF STANDARDIZATION
11.3 ISSUES RELATED TO LEACHABLES AND EXTRACTABLES
12 MARKET LANDSCAPE
12.1 MARKET OVERVIEW
12.2 MARKET SIZE & FORECAST
12.3 MARKET OPPORTUNITY
12.3.1 MARKET BY PRODUCT
12.3.2 MARKET BY APPLICATION
12.3.3 MARKET BY END-USER
12.3.4 MARKET BY METHOD
12.3.5 MARKET BY WORKFLOW
12.3.6 MARKET BY GEOGRAPHY
12.4 FIVE FORCES ANALYSIS
12.4.1 THREAT OF NEW ENTRANTS
12.4.2 BARGAINING POWER OF SUPPLIERS
12.4.3 BARGAINING POWER OF BUYERS
12.4.4 THREAT OF SUBSTITUTES
12.4.5 COMPETITIVE RIVALRY
13 PRODUCT TYPE
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 SINGLE-USE BIOPROCESSING EQUIPMENT
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
13.4 SIMPLE & PERIPHERAL DEVICES
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY
14 APPLICATION
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 MONOCLONAL ANTIBODIES
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
14.4 VACCINES
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 VACCINES MARKET BY GEOGRAPHY
14.5 CELL THERAPIES
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 CELL THERAPIES MARKET BY GEOGRAPHY
14.6 OTHERS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 OTHERS MARKET BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 BIOPHARMACEUTICAL MANUFACTURERS
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
15.4 CONTRACT MANUFACTURING ORGANIZATIONS (CMO)
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
15.5 R&D COMPANIES AND RESEARCH INSTITUTES
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY
16 METHOD
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 MARKET OVERVIEW
16.3 FILTRATION
16.3.1 MARKET OVERVIEW
16.3.2 MARKET SIZE & FORECAST
16.4 STORAGE & TRANSPORT
16.4.1 MARKET OVERVIEW
16.4.2 MARKET SIZE & FORECAST
16.5 CELL CULTURE
16.5.1 MARKET OVERVIEW
16.5.2 MARKET SIZE & FORECAST
16.6 MIXING
16.6.1 MARKET OVERVIEW
16.6.2 MARKET SIZE & FORECAST
16.7 PURIFICATION
16.7.1 MARKET OVERVIEW
16.7.2 MARKET SIZE & FORECAST
17 WORKFLOW
17.1 MARKET SNAPSHOT & GROWTH ENGINE
17.2 MARKET OVERVIEW
17.3 UPSTREAM
17.3.1 MARKET OVERVIEW
17.3.2 MARKET SIZE & FORECAST
17.4 DOWNSTREAM
17.4.1 MARKET OVERVIEW
17.4.2 MARKET SIZE & FORECAST
18 GEOGRAPHY
18.1 MARKET SNAPSHOT & GROWTH ENGINE
18.2 GEOGRAPHIC OVERVIEW
19 NORTH AMERICA
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 NORTH AMERICA MARKET BY PRODUCT TYPE
19.2.2 NORTH AMERICA MARKET BY APPLICATION
19.2.3 NORTH AMERICA MARKET BY END-USER
19.3 KEY COUNTRIES
19.3.1 US: MARKET SIZE & FORECAST
19.3.2 CANADA: MARKET SIZE & FORECAST
20 EUROPE
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 EUROPE MARKET BY PRODUCT TYPE
20.2.2 EUROPE MARKET BY APPLICATION
20.2.3 EUROPE MARKET BY END-USER
20.3 KEY COUNTRIES
20.3.1 GERMANY: MARKET SIZE & FORECAST
20.3.2 FRANCE: MARKET SIZE & FORECAST
20.3.3 SWITZERLAND: MARKET SIZE & FORECAST
20.3.4 UK: MARKET SIZE & FORECAST
20.3.5 ITALY: MARKET SIZE & FORECAST
20.3.6 SPAIN: MARKET SIZE & FORECAST
21 APAC
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 APAC MARKET BY PRODUCT TYPE
21.2.2 APAC MARKET BY APPLICATION
21.2.3 APAC MARKET BY END-USER
21.3 KEY COUNTRIES
21.3.1 CHINA: MARKET SIZE & FORECAST
21.3.2 JAPAN: MARKET SIZE & FORECAST
21.3.3 AUSTRALIA: MARKET SIZE & FORECAST
21.3.4 SOUTH KOREA: MARKET SIZE & FORECAST
21.3.5 INDIA: MARKET SIZE & FORECAST
22 LATIN AMERICA
22.1 MARKET OVERVIEW
22.2 MARKET SIZE & FORECAST
22.2.1 LATIN AMERICA MARKET BY PRODUCT TYPE
22.2.2 LATIN AMERICA MARKET BY APPLICATION
22.2.3 LATIN AMERICA MARKET BY END-USER
22.3 KEY COUNTRIES
22.3.1 BRAZIL: MARKET SIZE & FORECAST
22.3.2 MEXICO: MARKET SIZE & FORECAST
22.3.3 COLOMBIA: MARKET SIZE & FORECAST
22.3.4 ARGENTINA: MARKET SIZE & FORECAST
23 MIDDLE EAST & AFRICA
23.1 MARKET OVERVIEW
23.2 MARKET SIZE & FORECAST
23.2.1 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
23.2.2 MIDDLE EAST & AFRICA MARKET BY APPLICATION
23.2.3 MIDDLE EAST & AFRICA MARKET BY END-USER
23.3 KEY COUNTRIES
23.3.1 TURKEY: MARKET SIZE & FORECAST
23.3.2 SAUDI ARABIA: MARKET SIZE & FORECAST
23.3.3 UAE: MARKET SIZE & FORECAST
23.3.4 SOUTH AFRICA: MARKET SIZE & FORECAST
24 COMPETITIVE LANDSCAPE
24.1 COMPETITION OVERVIEW
24.1.1 VENDOR ACTIVITIES IN SINGLE-USE BIOPROCESSING MARKET
24.2 MARKET SHARE ANALYSIS
24.2.1 THERMO FISHER SCIENTIFIC
24.2.2 SARTORIUS STEDIM BIOTECH
24.2.3 DANAHER
24.2.4 MERCK KGAA
24.2.5 AVANTOR
25 KEY COMPANY PROFILES
25.1 THERMO FISHER SCIENTIFIC
25.1.1 BUSINESS OVERVIEW
25.1.2 PRODUCT OFFERINGS
25.1.3 KEY STRATEGIES
25.1.4 KEY STRENGTHS
25.1.5 KEY OPPORTUNITIES
25.2 SARTORIUS STEDIM BIOTECH
25.2.1 BUSINESS OVERVIEW
25.2.2 PRODUCT OFFERINGS
25.2.3 KEY STRATEGIES
25.2.4 KEY STRENGTHS
25.2.5 KEY OPPORTUNITIES
25.3 DANAHER
25.3.1 BUSINESS OVERVIEW
25.3.2 PRODUCT OFFERINGS
25.3.3 KEY STRATEGIES
25.3.4 KEY STRENGTHS
25.3.5 KEY OPPORTUNITIES
25.4 MERCK KGAA
25.4.1 BUSINESS OVERVIEW
25.4.2 PRODUCT OFFERINGS
25.4.3 KEY STRATEGIES
25.4.4 KEY STRENGTHS
25.4.5 KEY OPPORTUNITIES
25.5 AVANTOR
25.5.1 BUSINESS OVERVIEW
25.5.2 PRODUCT OFFERINGS
25.5.3 KEY STRATEGIES
25.5.4 KEY STRENGTHS
25.5.5 KEY OPPORTUNITIES
26 OTHER PROMINENT VENDORS
26.1 3I GROUP
26.1.1 BUSINESS OVERVIEW
26.1.2 PRODUCT OFFERINGS
26.2 3M
26.2.1 BUSINESS OVERVIEW
26.2.2 PRODUCT OFFERINGS
26.3 ABEC
26.3.1 BUSINESS OVERVIEW
26.3.2 PRODUCT OFFERINGS
26.4 ADOLF KÜHNER
26.4.1 BUSINESS OVERVIEW
26.4.2 PRODUCT OFFERINGS
26.5 ADVANTAPURE
26.5.1 BUSINESS OVERVIEW
26.5.2 PRODUCT OFFERINGS
26.6 BARRY-WEHMILLER COMPANIES
26.6.1 BUSINESS OVERVIEW
26.6.2 PRODUCT OFFERING
26.7 BROADLEY-JAMES
26.7.1 BUSINESS OVERVIEW
26.7.2 PRODUCT OFFERINGS
26.8 CELLTAINER BIOTECH
26.8.1 BUSINESS OVERVIEW
26.8.2 PRODUCT OFFERINGS
26.9 CERCELL A/S
26.9.1 BUSINESS OVERVIEW
26.9.2 PRODUCT OFFERINGS
26.10 CESCO BIOENGINEERING
26.10.1 BUSINESS OVERVIEW
26.10.2 PRODUCT OFFERINGS
26.11 CHARTER MEDICAL
26.11.1 BUSINESS OVERVIEW
26.11.2 PRODUCT OFFERINGS
26.12 COLDER PRODUCTS COMPANY
26.12.1 BUSINESS OVERVIEW
26.12.2 PRODUCT OFFERINGS
26.13 CORNING
26.13.1 BUSINESS OVERVIEW
26.13.2 PRODUCT OFFERINGS
26.14 DISTEK
26.14.1 BUSINESS OVERVIEW
26.14.2 PRODUCT OFFERINGS
26.15 DRM, DR. MUELLER
26.15.1 BUSINESS OVERVIEW
26.15.2 PRODUCT OFFERINGS
26.16 EMERSON ELECTRIC
26.16.1 BUSINESS OVERVIEW
26.16.2 PRODUCT OFFERINGS
26.17 ENTEGRIS
26.17.1 BUSINESS OVERVIEW
26.17.2 PRODUCT OFFERINGS
26.18 EPPENDORF
26.18.1 BUSINESS OVERVIEW
26.18.2 PRODUCT OFFERINGS
26.19 FOXX LIFE SCIENCES
26.19.1 BUSINESS OVERVIEW
26.19.2 PRODUCT OFFERINGS
26.20 GETINGE
26.20.1 BUSINESS OVERVIEW
26.20.2 PRODUCT OFFERINGS
26.21 HIGH-PURITY NEW ENGLAND
26.21.1 BUSINESS OVERVIEW
26.21.2 PRODUCT OFFERINGS
26.22 HOLLAND APPLIED TECHNOLOGIES
26.22.1 BUSINESS OVERVIEW
26.22.2 PRODUCT OFFERINGS
26.23 LONZA
26.23.1 BUSINESS OVERVIEW
26.23.2 PRODUCT OFFERINGS
26.24 MEISSNER FILTRATION PRODUCTS
26.24.1 BUSINESS OVERVIEW
26.24.2 PRODUCT OFFERINGS
26.25 NEW HORIZON BIOTECH
26.25.1 BUSINESS OVERVIEW
26.25.2 PRODUCT OFFERINGS
26.26 OMNIBRX BIOTECHNOLOGIES
26.26.1 BUSINESS OVERVIEW
26.26.2 PRODUCT OFFERINGS
26.27 PARKER HANNIFIN
26.27.1 BUSINESS OVERVIEW
26.27.2 PRODUCT OFFERINGS
26.28 PENDOTECH
26.28.1 BUSINESS OVERVIEW
26.28.2 PRODUCT OFFERINGS
26.29 PBS BIOTECH
26.29.1 BUSINESS OVERVIEW
26.29.2 PRODUCT OFFERINGS
26.30 REPLIGEN
26.30.1 BUSINESS OVERVIEW
26.30.2 PRODUCT OFFERINGS
26.31 SAINT-GOBAIN
26.31.1 BUSINESS OVERVIEW
26.31.2 PRODUCT OFFERINGS
26.32 SENTINEL PROCESS SYSTEMS
26.32.1 BUSINESS OVERVIEW
26.32.2 PRODUCT OFFERINGS
26.33 SOLARIS BIOTECHNOLOGY
26.33.1 BUSINESS OVERVIEW
26.33.2 PRODUCT OFFERINGS
26.34 SYSBIOTECH
26.34.1 BUSINESS OVERVIEW
26.34.2 PRODUCT OFFERINGS
26.35 WATSON-MARLOW FLUID TECHNOLOGY SOLUTIONS
26.35.1 BUSINESS OVERVIEW
26.35.2 PRODUCT OFFERINGS
26.36 WEIGAO GROUP
26.36.1 BUSINESS OVERVIEW
26.36.2 PRODUCT OFFERINGS
26.37 W.L. GORE & ASSOCIATES
26.37.1 BUSINESS OVERVIEW
26.37.2 PRODUCT OFFERINGS
27 REPORT SUMMARY
27.1 KEY TAKEAWAYS
27.2 STRATEGIC RECOMMENDATIONS
28 QUANTITATIVE SUMMARY
28.1 MARKET BY PRODUCT TYPE
28.1.1 NORTH AMERICA MARKET BY PRODUCT TYPE
28.1.2 EUROPE MARKET BY PRODUCT TYPE
28.1.3 APAC MARKET BY PRODUCT TYPE
28.1.4 LATIN AMERICA MARKET BY PRODUCT TYPE
28.1.5 MIDDLE EAST & AFRICA MARKET BY PRODUCT TYPE
28.2 MARKET BY APPLICATION
28.2.1 NORTH AMERICA MARKET BY APPLICATION
28.2.2 EUROPE MARKET BY APPLICATION
28.2.3 APAC MARKET BY APPLICATION
28.2.4 LATIN AMERICA MARKET BY APPLICATION
28.2.5 MIDDLE EAST & AFRICA MARKET BY APPLICATION
28.3 MARKET BY END-USER
28.3.1 NORTH AMERICA MARKET BY END-USER
28.3.2 EUROPE MARKET BY END-USER
28.3.3 APAC MARKET BY END-USER
28.3.4 LATIN AMERICA MARKET BY END-USER
28.3.5 MIDDLE EAST & AFRICA MARKET BY END-USER
28.4 MARKET BY METHOD
28.5 MARKET BY WORKFLOW
28.6 MARKET BY GEOGRAPHY
28.6.1 SINGLE-USE BIOPROCESSING EQUIPMENT MARKET BY GEOGRAPHY
28.6.2 SIMPLE & PERIPHERAL DEVICES MARKET BY GEOGRAPHY
28.6.3 MONOCLONAL ANTIBODIES (MABS) MARKET BY GEOGRAPHY
28.6.4 VACCINES MARKET BY GEOGRAPHY
28.6.5 CELL THERAPIES MARKET BY GEOGRAPHY
28.6.6 OTHERS MARKET BY GEOGRAPHY
28.6.7 BIOPHARMACEUTICAL MANUFACTURERS MARKET BY GEOGRAPHY
28.6.8 CONTRACT MANUFACTURING ORGANIZATIONS (CMOS) MARKET BY GEOGRAPHY
28.6.9 R&D COMPANIES AND RESEARCH INSTITUTES MARKET BY GEOGRAPHY
29 APPENDIX
29.1 ABBREVIATIONS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings